Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in Group 2 Pulmonary Hypertension with CpcPH
NCT06350773Completed
- Sponsor
- Beni Suef University
- Start
- Mar 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tadalafil in pulmonary hypertension (PH) (2 arms), sponsored by Beni Suef University. Primary endpoint: Functional capacity at 12 weeks. Started Mar 2023; status: completed.
02
Drugs
tadalafil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT06350773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06350773.